The Alert India News With Reality
Related Articles
Researchers have found that two new gene-based blood tests can reliably detect previously unidentifiable forms of one of the most aggressive forms of skin cancer.
Having quick and accurate monitoring tools for all types of metastatic melanoma, the medical term for the disease, may make it easier for physicians to detect early signs of cancer recurrence, the researchers said.
The new blood tests, which take only 48 hours, are currently only available for research purposes.
“Our goal is to use these tests to make more informed treatment decisions and, specifically, to identify as early as possible when a treatment has stopped working, cancer growth has resumed, and the patient needs to switch therapy,” said senior study investigator and dermatologist David Polsky, Professor at NYU Langone Medical Center in New York.
